Opus Genetics (IRD) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.43% |
| Dec 31, 2025 | -59.70% |
| Sep 30, 2025 | 40.04% |
| Jun 30, 2025 | -14.18% |
| Mar 31, 2025 | -20.92% |
| Dec 31, 2024 | -44.99% |
| Sep 30, 2024 | 29.65% |
| Jun 30, 2024 | -27.57% |
| Mar 31, 2024 | -225.68% |
| Dec 31, 2023 | 251.45% |
| Sep 30, 2023 | -403.64% |
| Jun 30, 2023 | 127.13% |
| Mar 31, 2023 | -112.66% |
| Dec 31, 2022 | 740.08% |
| Sep 30, 2022 | -18.09% |
| Jun 30, 2022 | 38.27% |
| Mar 31, 2022 | -9.28% |
| Dec 31, 2021 | -57.53% |
| Sep 30, 2021 | 17.19% |
| Jun 30, 2021 | 25.53% |
| Mar 31, 2021 | -33.36% |
| Dec 31, 2020 | -312.69% |
| Sep 30, 2020 | -62.21% |
| Jun 30, 2020 | 11.07% |
| Mar 31, 2020 | -114.74% |
| Dec 31, 2019 | 308.83% |
| Sep 30, 2019 | -31.18% |
| Jun 30, 2019 | 58.74% |
| Mar 31, 2019 | 4.91% |
| Dec 31, 2018 | -9.93% |
| Sep 30, 2018 | 5.64% |
| Jun 30, 2018 | 20.48% |
| Mar 31, 2018 | -49.01% |
| Dec 31, 2017 | -8.93% |
| Sep 30, 2017 | 16.11% |
| Jun 30, 2017 | 1.43% |
| Mar 31, 2017 | -179.34% |
| Dec 31, 2016 | 52.16% |
| Sep 30, 2016 | 38.37% |
| Jun 30, 2016 | -42.53% |
| Mar 31, 2016 | 19.54% |
| Dec 31, 2015 | 2.75% |
| Sep 30, 2015 | -3.07% |
| Jun 30, 2015 | -8.91% |
| Mar 31, 2015 | -38.45% |
| Dec 31, 2014 | -11.67% |
| Sep 30, 2014 | 11.62% |
| Jun 30, 2014 | -14.77% |
| Mar 31, 2014 | -14.55% |
| Dec 31, 2013 | -30.54% |
| Sep 30, 2013 | 31.11% |
| Jun 30, 2013 | -61.37% |
| Mar 31, 2013 | -44.59% |
| Dec 31, 2012 | 34.93% |
| Sep 30, 2012 | 16.68% |
| Jun 30, 2012 | -3.31% |
| Mar 31, 2012 | 60.81% |
| Dec 31, 2011 | -54.60% |
| Sep 30, 2011 | 37.57% |
| Jun 30, 2011 | -108.87% |
| Mar 31, 2011 | -0.19% |
| Dec 31, 2010 | -52.28% |